CDNA
CareDx IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$1.12B
P/E Ratio
—
EPS
$-0.16
Beta
2.49
52W High
$23.24
52W Low
$10.96
50-Day MA
$19.40
200-Day MA
$17.40
Dividend Yield
—
Profit Margin
-1.98%
Forward P/E
94.34
PEG Ratio
-0.12
About CareDx Inc
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $412.82M |
| Gross Profit (TTM) | $284.37M |
| EBITDA | $2.32M |
| Operating Margin | 1.53% |
| Return on Equity | -2.37% |
| Return on Assets | -1.80% |
| Revenue/Share (TTM) | $7.90 |
| Book Value | $6.12 |
| Price-to-Book | 3.56 |
| Price-to-Sales (TTM) | 2.71 |
| EV/Revenue | 2.313 |
| EV/EBITDA | 172.49 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.00% |
| Shares Outstanding | $51.66M |
| Float | $49.48M |
| % Insiders | 3.38% |
| % Institutions | 101.87% |
Historical Volatility
HV 10-Day
35.61%
HV 20-Day
38.04%
HV 30-Day
82.67%
HV 60-Day
67.52%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($25.80 target)
3
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026